HIV VACCINE TRIALS NETWORK
🇺🇸United States
HIV Vaccine Breakthrough: New Candidate Successfully Generates Broadly Neutralizing Antibodies
NIAID-supported clinical trial demonstrates that an HIV vaccine candidate can elicit broadly neutralizing antibodies (bNAbs) targeting the membrane proximal external region (MPER) of HIV, a crucial step toward developing an effective preventive vaccine.